Theoretical modeling reveals that regulatory T cells increase T-cell interaction with antigen-presenting cells for stable immune tolerance.
T-APC interaction
heterogeneity
lymphopenia
proliferation
regulation model
Journal
International immunology
ISSN: 1460-2377
Titre abrégé: Int Immunol
Pays: England
ID NLM: 8916182
Informations de publication
Date de publication:
16 10 2019
16 10 2019
Historique:
received:
22
01
2019
accepted:
24
05
2019
pubmed:
28
5
2019
medline:
14
4
2020
entrez:
28
5
2019
Statut:
ppublish
Résumé
The immune system in tolerance maintains cell diversity without responding to self-antigens. Foxp3-expressing CD25+CD4+ regulatory T cells (Tregs) inhibit T-cell activation through various molecular mechanisms. However, several key questions are still not resolved, including how Tregs control the immune response on the basis of their self-skewed T-cell receptor repertoire and how Tregs avoid impeding relevant immunity against pathogens. Here, we show that Tregs promote the proliferation of conventional T cells in the presence of excessive co-stimulation when murine T cells are stimulated in vitro with allogeneic antigen-presenting cells (APCs). Antigen-specific Tregs increase the number of cells interacting with dendritic cells (DCs) by increasing the number of viable DCs and the expression of adhesion molecules on DCs. Theoretical simulations and mathematical models representing the dynamics of T-APC interaction and T-cell numbers in a lymph node indicate that Tregs reduce the dissociation probability of T cells from APCs and increase the new association. These functions contribute to tolerance by enhancing the interaction of low-affinity T cells with APCs. Supporting the theoretical analyses, we found that reducing the T-cell numbers in mice increases the ratio of specific T cells among CD4+ T cells after immunization and effectively induces autoimmune diabetes in non obese diabetes mice. Thus, as a critical function, antigen-specific Tregs stabilize the immune state, irrespective of it being tolerant or responsive, by augmenting T-APC interaction. We propose a novel regulation model in which stable tolerance with large heterogeneous populations proceeds to a specific immune response through a transient state with few populations.
Identifiants
pubmed: 31131864
pii: 5498862
doi: 10.1093/intimm/dxz043
pmc: PMC6794947
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
743-753Informations de copyright
© The Author(s) 2019. Published by Oxford University Press on behalf of The Japanese Society for Immunology.
Références
Proc Natl Acad Sci U S A. 2008 Jul 22;105(29):10113-8
pubmed: 18635688
J Exp Med. 1998 Jul 20;188(2):287-96
pubmed: 9670041
Eur J Immunol. 2005 May;35(5):1336-41
pubmed: 15827965
Nat Immunol. 2006 Apr;7(4):401-10
pubmed: 16532000
Science. 2008 May 30;320(5880):1220-4
pubmed: 18436744
PLoS Biol. 2016 May 19;14(5):e1002463
pubmed: 27196433
Immunity. 2009 May;30(5):636-45
pubmed: 19464986
Cell Rep. 2015 May 26;11(8):1208-19
pubmed: 26004178
Nat Immunol. 2007 Dec;8(12):1353-62
pubmed: 17982458
Nat Chem Biol. 2009 Jun;5(6):403-5
pubmed: 19430485
Nature. 2002 Dec 5;420(6915):502-7
pubmed: 12466842
J Immunol. 1995 Aug 1;155(3):1151-64
pubmed: 7636184
Nat Immunol. 2008 Jun;9(6):658-66
pubmed: 18469818
Science. 2007 Mar 23;315(5819):1716-9
pubmed: 17379809
Int Immunol. 1998 Dec;10(12):1969-80
pubmed: 9885918
Nat Rev Immunol. 2008 Jul;8(7):523-32
pubmed: 18566595
Nature. 2010 Sep 9;467(7312):167-73
pubmed: 20829787
Immunol Rev. 2007 Apr;216:48-68
pubmed: 17367334
Annu Rev Immunol. 2012;30:531-64
pubmed: 22224781
Nature. 2007 Feb 22;445(7130):936-40
pubmed: 17237761
Front Immunol. 2012 May 25;3:125
pubmed: 22654881
J Exp Med. 2007 Jan 22;204(1):57-63
pubmed: 17200412
Immunity. 2015 Jun 16;42(6):1116-29
pubmed: 26084026
Annu Rev Immunol. 2009;27:551-89
pubmed: 19302048
Proc Natl Acad Sci U S A. 2013 Jul 16;110(29):11833-8
pubmed: 23818603
Nat Immunol. 2015 Aug;16(8):871-9
pubmed: 26147684
Science. 2008 Oct 10;322(5899):271-5
pubmed: 18845758
Front Immunol. 2018 Oct 30;9:2461
pubmed: 30425712
Immunity. 2006 Dec;25(6):851-5
pubmed: 17174925
Immunol Rev. 1996 Feb;149:97-125
pubmed: 9005222
Nat Rev Immunol. 2016 Apr;16(4):220-33
pubmed: 27026074
Nature. 2008 May 22;453(7194):544-7
pubmed: 18497826
Nature. 2007 Feb 22;445(7130):931-5
pubmed: 17237765
Proc Natl Acad Sci U S A. 2010 Feb 16;107(7):3058-63
pubmed: 20133667
J Med Genet. 2002 Aug;39(8):537-45
pubmed: 12161590
Proc Natl Acad Sci U S A. 2013 Jun 4;110(23):E2116-25
pubmed: 23690575
Nature. 2003 Nov 27;426(6965):454-60
pubmed: 14647385
Immunity. 2010 Dec 14;33(6):942-54
pubmed: 21145762
PLoS One. 2016 Sep 26;11(9):e0163134
pubmed: 27668873
PLoS One. 2014 Jan 23;9(1):e86762
pubmed: 24466225
Cell. 2004 Apr 16;117(2):265-77
pubmed: 15084263
Science. 2012 Oct 26;338(6106):532-6
pubmed: 23112334
Nature. 2017 Jun 15;546(7658):431-435
pubmed: 28607484
Nat Med. 2012 Jan 06;18(1):54-8
pubmed: 22227673
Immunity. 2007 Sep;27(3):493-504
pubmed: 17869133